Tag: #Global Trends

On December 9, 2025, a major pharmaceutical corporation based in New York announced it had entered into an exclusive global... Read more

(ASH Congress) – AstraZeneca (AZ) announced positive clinical data for its leading cell therapy candidate, AZD0120 (formerly GC012F), for the... Read more

The pharmaceutical companies Crescent Biopharma (US-based) and Kelun-Biotech (China-based) have announced a strategic partnership to exchange licensing rights for two... Read more

(ORLANDO) – At an American Society of Hematology (ASH) meeting, the pharmaceutical company Eli Lillypresented results from a critical head-to-head... Read more

Alexion Pharmaceuticals, the rare disease unit of AstraZeneca, has expanded its partnership with biotech company Neurimmune by licensing a second... Read more

A therapeutics company has announced a funding agreement worth $275 million with a financial fund specializing in pharmaceutical royalties. The... Read more

A therapeutics company has announced positive topline results from its pivotal Phase 3 HOPE-3 clinical trial, evaluating the efficacy of... Read more

The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for... Read more

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,... Read more